levofloxacin has been researched along with Torsade de Pointes in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Khajavian, S; Moradi, F; Rajabian, M; Ruzbahani, M; Shahbazi, F; Shahsavari, S; Shojaei, L; Tamasoki, N | 1 |
| Groo, VL; Sadr, R; Tilton, JJ | 1 |
| Chen, JC; Kuo, CW; Lin, CC; Tsai, LH; Weng, YM | 1 |
| Diehl, NN; Getz, TW; Heckman, MG; Mentel, JJ; Pagan, RJ; Palmer, WC; Racho, RG; Ray, JC; Sears, SP; Seeger, KM; Serra-Valentin, NA; Snipelisky, DF; Stancampiano, FF | 1 |
| Afshar, H; Birnbaum, Y; Patel, PD | 1 |
| Estes, LL; Wilson, JW; Zeuli, JD | 1 |
| Gandhi, PJ; Menezes, PA; Ramaswamy, K; Rivera, AL; Vu, HT | 1 |
| Amankwa, K; Krishnan, SC; Tisdale, JE | 1 |
| Cox, CD; Meyerrose, GE; Peeters, MJ; Seifert, CF; Tsikouris, JP | 1 |
| Kawai, H; Komiya, M; Matsumoto, T; Nakayasu, T; Shimada, J; Yamaguchi, H; Yokoyama, H | 1 |
| Breithardt, G; Cakir, Y; Eckardt, L; Engelen, MA; Haverkamp, W; Hilker, E; Milberg, P; Mönnig, G; Osada, N; Ramtin, S; Stypmann, J | 1 |
| Chiba, K; Hashimoto, K; Satoh, Y; Shiina, H; Sugiyama, A | 1 |
| Frothingham, R | 1 |
1 trial(s) available for levofloxacin and Torsade de Pointes
| Article | Year |
|---|---|
Effects of three fluoroquinolones on QT analysis after standard treatment courses.
Topics: Analysis of Variance; Aza Compounds; Ciprofloxacin; Cross-Over Studies; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Levofloxacin; Long QT Syndrome; Male; Moxifloxacin; Ofloxacin; Quinolines; Statistics, Nonparametric; Torsades de Pointes | 2006 |
12 other study(ies) available for levofloxacin and Torsade de Pointes
| Article | Year |
|---|---|
Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia.
Topics: Adult; Aged; Cross-Sectional Studies; Electrocardiography; Female; Humans; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Pneumonia; Torsades de Pointes | 2020 |
Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes.
Topics: Adult; Electrocardiography; Female; Fluconazole; Humans; Levofloxacin; Long QT Syndrome; Risk Factors; Torsades de Pointes | 2019 |
Risk screening for long QT prior to prescribing levofloxacin.
Topics: Aged; Anti-Bacterial Agents; Contraindications; Electrocardiography; Emergency Service, Hospital; Female; Humans; Levofloxacin; Long QT Syndrome; Pneumonia, Bacterial; Risk Factors; Torsades de Pointes | 2014 |
Rare Incidence of Ventricular Tachycardia and Torsades de Pointes in Hospitalized Patients With Prolonged QT Who Later Received Levofloxacin: A Retrospective Study.
Topics: Aged; Anti-Bacterial Agents; Female; Hospitalization; Humans; Incidence; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Retrospective Studies; Tachycardia, Ventricular; Torsades de Pointes | 2015 |
Levofloxacin-induced torsades de pointes.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Coronary Angiography; Diagnosis, Differential; Electrocardiography; Female; Heart Rate; Humans; Levofloxacin; Myocardial Infarction; Ofloxacin; Torsades de Pointes | 2010 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient.
Topics: Anti-Infective Agents; Antifungal Agents; Fluconazole; Humans; Intensive Care Units; Levofloxacin; Male; Middle Aged; Monitoring, Physiologic; Ofloxacin; Torsades de Pointes; United States | 2003 |
Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.
Topics: Aged; Cardiovascular Diseases; Female; Fluoroquinolones; Humans; Levofloxacin; Lupus Erythematosus, Systemic; Ofloxacin; Osteomyelitis; Risk Factors; Torsades de Pointes | 2004 |
Post-marketing surveillance of the safety of levofloxacin in Japan.
Topics: Achilles Tendon; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemia; Japan; Levofloxacin; Liver Diseases; Long QT Syndrome; Male; Middle Aged; Ofloxacin; Photosensitivity Disorders; Product Surveillance, Postmarketing; Seizures; Torsades de Pointes | 2007 |
Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
Topics: Action Potentials; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Fluoroquinolones; Heart Conduction System; In Vitro Techniques; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Rabbits; Torsades de Pointes | 2007 |
Proarrhythmic effects of fluoroquinolone antibacterial agents: in vivo effects as physiologic substrate for torsades.
Topics: Action Potentials; Animals; Anti-Infective Agents; Dogs; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Heart; Heart Block; Levofloxacin; Long QT Syndrome; Male; Models, Animal; Ofloxacin; Torsades de Pointes; Ventricular Dysfunction, Right | 2000 |
Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Electrocardiography; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies; Torsades de Pointes | 2001 |